(NASDAQ: OMGA) Omega Therapeutics's forecast annual revenue growth rate of 218.02% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.22%, and it is also forecast to beat the US market's average forecast revenue growth rate of 9.95%.
Omega Therapeutics's revenue in 2024 is $4,939,000.On average, 3 Wall Street analysts forecast OMGA's revenue for 2024 to be $267,832,607, with the lowest OMGA revenue forecast at $212,898,242, and the highest OMGA revenue forecast at $319,898,913. On average, 3 Wall Street analysts forecast OMGA's revenue for 2025 to be $163,589,686, with the lowest OMGA revenue forecast at $82,732,478, and the highest OMGA revenue forecast at $220,619,940.
In 2027, OMGA is forecast to generate $1,656,579,974 in revenue, with the lowest revenue forecast at $182,011,451 and the highest revenue forecast at $3,131,148,498.